Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is United States  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
O
Rose KM, Tyroler HA, Nardo CJ, et al. "Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study." Am J Hypertens. 2000;13(6 Pt 1):571-8.
Bell EJ, Agarwal SK, Cushman M, Heckbert SR, Lutsey PL. "Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies." Am J Hypertens. 2016;29(5):634-40.
Juraschek SP, Daya N, Appel LJ, et al. "Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle-Aged Adults." J Am Heart Assoc. 2018;7(10).
Rose KM, Couper D, Eigenbrodt ML, Mosley TH, A Sharrett R, Gottesman RF. "Orthostatic hypotension and cognitive function: the Atherosclerosis Risk in Communities Study." Neuroepidemiology. 2010;34(1):1-7.
Kim H, Rebholz CM, Garcia-Larsen V, Steffen LM, Coresh JJ. "Operational Differences in Plant-Based Diet Indices Affect the Ability to Detect Associations with Incident Hypertension in Middle-Aged US Adults." J Nutr. 2020;150(4):842-850.
Palta P, Chen H, Deal JA, et al. "Olfactory function and neurocognitive outcomes in old age: The Atherosclerosis Risk in Communities Neurocognitive Study." Alzheimers Dement. 2018;14(8):1015-1021.
Boland LL, Folsom AR, Sorlie PD, et al. "Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study)." Am J Cardiol. 2002;90(9):927-31.
Mirabelli MC, London SJ, Charles LE, Pompeii LA, Wagenknecht LE. "Occupation and the prevalence of respiratory health symptoms and conditions: the Atherosclerosis Risk in Communities Study." J Occup Environ Med. 2012;54(2):157-65.
Nagayoshi M, Punjabi NM, Selvin E, et al. "Obstructive sleep apnea and incident type 2 diabetes." Sleep Med. 2016;25:156-161.
Adabag S, Huxley RR, Norby FL, et al. "Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study." Heart. 2015;101(3):215-21.
Bryant MJ, Stevens J, Truesdale KP, Mosley T, Chambless L. "Obesity and vital exhaustion: analysis of the Atherosclerosis Risk in the Communities study." Obesity (Silver Spring). 2008;16(7):1545-51.
Ndumele CE, Matsushita K, Lazo M, et al. "Obesity and Subtypes of Incident Cardiovascular Disease." J Am Heart Assoc. 2016;5(8).
N
Bower JK, Lazo M, Matsushita K, Rubin J, Hoogeveen RC, Ballantyne CM. "N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study." Am J Hypertens. 2015;28(10):1262-6.
Whitman IR, Vittinghoff E, Defilippi CR, et al. "NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure." J Am Heart Assoc. 2019;8(7):e010868.
Matsushita K, Sang Y, Chen J, et al. "Novel "Predictor Patch" Method for Adding Predictors Using Estimates From Outside Datasets - A Proof-of-Concept Study Adding Kidney Measures to Cardiovascular Mortality Prediction." Circ J. 2019;83(9):1876-1882.
Lee CR, North KE, Bray MS, et al. "NOS3 polymorphisms, cigarette smoking, and cardiovascular disease risk: the Atherosclerosis Risk in Communities study." Pharmacogenet Genomics. 2006;16(12):891-9.
Love S-AM, North KE, Zeng D, et al. "Nine-Year Ethanol Intake Trajectories and Their Association With 15-Year Cognitive Decline Among Black and White Adults." Am J Epidemiol. 2020;189(8):788-800.
Borrell LN, Diez Roux AV, Rose K, Catellier D, Clark BL. "Neighbourhood characteristics and mortality in the Atherosclerosis Risk in Communities Study." Int J Epidemiol. 2004;33(2):398-407.
Foraker RE, Rose KM, Whitsel EA, Suchindran CM, Wood JL, Rosamond WD. "Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: atherosclerosis risk in communities (ARIC) community surveillance." BMC Public Health. 2010;10:632.
Foraker RE, Patel MD, Whitsel EA, Suchindran CM, Heiss G, Rose KM. "Neighborhood socioeconomic disparities and 1-year case fatality after incident myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Community Surveillance (1992-2002)." Am Heart J. 2013;165(1):102-7.
Rose KM, Foraker RE, Heiss G, Rosamond WD, Suchindran CM, Whitsel EA. "Neighborhood socioeconomic and racial disparities in angiography and coronary revascularization: the ARIC surveillance study." Ann Epidemiol. 2012;22(9):623-9.
Diez Roux AV, Merkin SS, Arnett D, et al. "Neighborhood of residence and incidence of coronary heart disease." N Engl J Med. 2001;345(2):99-106.
Foraker RE, Rose KM, McGinn AP, et al. "Neighborhood income, health insurance, and prehospital delay for myocardial infarction: the atherosclerosis risk in communities study." Arch Intern Med. 2008;168(17):1874-9.
Beydoun MA, Kaufman JS, Sloane PD, Heiss G, Ibrahim J. "n-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the Atherosclerosis Risk in Communities (ARIC) study." Public Health Nutr. 2008;11(1):17-29.
M
O'Seaghdha CM, Parekh RS, Hwang S-J, et al. "The MYH9/APOL1 region and chronic kidney disease in European-Americans." Hum Mol Genet. 2011;20(12):2450-6.
Liao D, Sloan RP, Cascio WE, et al. "Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study." Diabetes Care. 1998;21(12):2116-22.
Perova NV, Davis CE, Tao S, et al. "Multi-country comparison of plasma lipid relationship to years of schooling in men and women." Int J Epidemiol. 2001;30(2):371-9.
Kocarnik JM, Pendergrass SA, Carty CL, et al. "Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study." Circ Cardiovasc Genet. 2014;7(2):178-88.
Camplain R, Kucharska-Newton AMaria, Cuthbertson CC, Wright JD, Alonso A. "Misclassification of incident hospitalized and outpatient heart failure in administrative claims data: the Atherosclerosis Risk in Communities (ARIC) study." Pharmacoepidemiol Drug Saf. 2017;26(4):421-428.
Savitz ST, Stearns SC, Groves JS, Kucharska-Newton AMaria, Bengtson LGS. "Mind the Gap: Hospitalizations from Multiple Sources in a Longitudinal Study." Value Health. 2017;20(6):777-784.
Petruski-Ivleva N, Kucharska-Newton AMaria, Palta P, et al. "Milk Intake at Midlife and Cognitive Decline over 20 Years. The Atherosclerosis Risk in Communities (ARIC) Study." Nutrients. 2017;9(10).
Johnson AM, Rose KM, Elder GH, Chambless LE, Kaufman JS, Heiss G. "Military combat and risk of coronary heart disease and ischemic stroke in aging men: The Atherosclerosis Risk in Communities (ARIC) study." Ann Epidemiol. 2010;20(2):143-50.
Johnson AM, Rose KM, Elder GH, Chambless LE, Kaufman JS, Heiss G. "Military combat and burden of subclinical atherosclerosis in middle aged men: the ARIC study." Prev Med. 2010;50(5-6):277-81.
Rose KM, Wong TY, Carson AP, Couper DJ, Klein R, Sharrett AR. "Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study." Neurology. 2007;68(20):1694-700.
Rose KM, Carson AP, Sanford CP, et al. "Migraine and other headaches: associations with Rose angina and coronary heart disease." Neurology. 2004;63(12):2233-9.
X Androulakis M, Sen S, Kodumuri N, et al. "Migraine Age of Onset and Association With Ischemic Stroke in Late Life: 20 Years Follow-Up in ARIC." Headache. 2019;59(4):556-566.
Walker KA, Power MC, Hoogeveen RC, et al. "Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study." Stroke. 2017;48(12):3196-3202.
B Windham G, Griswold ME, Wilkening SR, et al. "Midlife Smaller and Larger Infarctions, White Matter Hyperintensities, and 20-Year Cognitive Decline: A Cohort Study." Ann Intern Med. 2019;171(6):389-396.
González HM, Tarraf W, Harrison K, et al. "Midlife cardiovascular health and 20-year cognitive decline: Atherosclerosis Risk in Communities Study results." Alzheimers Dement. 2018;14(5):579-589.
Power MC, Tingle JV, Reid RI, et al. "Midlife and Late-Life Vascular Risk Factors and White Matter Microstructural Integrity: The Atherosclerosis Risk in Communities Neurocognitive Study." J Am Heart Assoc. 2017;6(5).
Jones SB, Loehr LR, Avery CL, Gottesman RF, Wruck L, Shahar E. "Midlife Alcohol Consumption and the Risk of Stroke in the Atherosclerosis Risk in Communities Study." Stroke. 2015;46(11):3124-30.
Hubbard LD, Brothers RJ, King WN, et al. "Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study." Ophthalmology. 1999;106(12):2269-80.
Zheng Y, Yu B, Alexander D, Steffen LM, Nettleton JA. "Metabolomic patterns and alcohol consumption in African Americans in the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 2014;99(6):1470-8.
Gurka MJ, Guo Y, Filipp SL. "Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes." Cardiovasc Diabetol. 2018;17(1):17.
Ballantyne CM, Hoogeveen RC, McNeill AM, et al. "Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study." Int J Obes (Lond). 2008;32 Suppl 2:S21-4.
Tande AJ, Platz EA, Folsom AR. "The metabolic syndrome is associated with reduced risk of prostate cancer." Am J Epidemiol. 2006;164(11):1094-102.
Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. "A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study." Diabetes Care. 1996;19(5):414-8.
Hess PL, Al-Khalidi HR, Friedman DJ, et al. "The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study." J Am Heart Assoc. 2017;6(8).
Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. "The metabolic syndrome and risk of incident colorectal cancer." Cancer. 2006;107(1):28-36.
Chen CTL, Liu C-T, Chen GK, et al. "Meta-analysis of loci associated with age at natural menopause in African-American women." Hum Mol Genet. 2014;23(12):3327-42.
O'Brien EC, Rose KM, Suchindran CM, et al. "Medication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction." Heart. 2013;99(11):767-73.
Sueta CA, Rodgers JE, Chang PP, Zhou L, Thudium EM, Kucharska-Newton AMaria. "Medication Adherence Based on Part D Claims for Patients With Heart Failure After Hospitalization (from the Atherosclerosis Risk in Communities Study)." Am J Cardiol. 2015;116(3):413-9.
Yong F, Heiss G, Couper DJ, Meyer ML, Cheng S. "Measurement Repeatability of Central and Peripheral Blood Pressures: The ARIC Study." Am J Hypertens. 2017;30(10):978-984.
Selvin E, Coresh J, Zhu H, Folsom A, Steffes MW. "Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study." J Diabetes. 2010;2(2):118-24.
Henderson CM, Lutsey PL, Misialek JR, Laha TJ, Selvin E, Eckfeldt JH. "Measurement by a Novel LC-MS/MS Methodology Reveals Similar Serum Concentrations of Vitamin D-Binding Protein in Blacks and Whites." Clin Chem. 2016;62(1):179-87.
L
Mirabelli MC, Preisser JS, Loehr LR, et al. "Lung function decline over 25 years of follow-up among black and white adults in the ARIC study cohort." Respir Med. 2016;113:57-64.
Oelsner EC, Balte PP, Bhatt SP, et al. "Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study." Lancet Respir Med. 2020;8(1):34-44.
Qian Z, Liao D, Lin H-M, Whitsel EA, Rose KM, Duan Y. "Lung function and long-term exposure to air pollutants in middle-aged American adults." Arch Environ Occup Health. 2005;60(3):156-63.
Sumida K, Kwak L, Grams ME, et al. "Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2017;70(5):675-685.
Schroeder EB, Welch V L, Couper D, et al. "Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2003;158(12):1171-81.
Duncan BB, Schmidt M I, Pankow JS, et al. "Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study." Diabetes. 2003;52(7):1799-805.
O'Seaghdha CM, Hwang S-J, Bhavsar NA, et al. "Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population." Am J Kidney Dis. 2011;57(6):841-9.
Folsom AR, Ma J, Eckfeldt JH, Nieto FJ, Metcalf PA, Barnes RW. "Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Ann Epidemiol. 1995;5(3):186-91.
Avery CL, Mills KT, Chambless LE, et al. "Long-term association between self-reported signs and symptoms and heart failure hospitalizations: the Atherosclerosis Risk In Communities (ARIC) Study." Eur J Heart Fail. 2010;12(3):232-8.
Folsom AR, Lutsey PL, Heckbert SR, et al. "Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism." J Thromb Haemost. 2018;16(10):1964-1972.
Nettleton JA, Volcik KA, Demerath EW, Boerwinkle E, Folsom AR. "Longitudinal changes in triglycerides according to ANGPTL4[E40K] genotype and longitudinal body weight change in the atherosclerosis risk in communities study." Ann Epidemiol. 2008;18(11):842-6.
Wang SY, Tan ASL, Claggett B, et al. "Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities Study." JAMA Cardiol. 2019;4(12):1203-1212.
Mondul AM, Joshu CE, Barber JR, et al. "Longer-term Lipid-lowering Drug Use and Risk of Incident and Fatal Prostate Cancer in Black and White Men in the ARIC Study." Cancer Prev Res (Phila). 2018;11(12):779-788.
Lutsey PL, Cushman M, Heckbert SR, Tang W, Folsom AR. "Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE)." Thromb Haemost. 2011;106(1):113-20.
Stevens J, Erber E, Truesdale KP, Wang C-H, Cai J. "Long- and short-term weight change and incident coronary heart disease and ischemic stroke: the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2013;178(2):239-48.
Schneider ALC, Lazo M, Ndumele CE, et al. "Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study." Diabet Med. 2013;30(8):926-33.
Ballantyne CM, Hoogeveen RC, Bang H, et al. "Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 2004;109(7):837-42.
Nambi V, Hoogeveen RC, Chambless L, et al. "Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2009;40(2):376-81.
Garg PK, Norby FL, Polfus LM, et al. "Lipoprotein-associated phospholipase A and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC)." Atherosclerosis. 2018;268:12-18.
Schreiner PJ. "Lipoprotein(a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: the Atherosclerosis Risk in Communities (ARIC) Study." Chem Phys Lipids. 1994;67-68:405-10.
Schreiner PJ, Chambless LE, Brown SA, Watson RL, Toole J, Heiss G. "Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities." Ann Epidemiol. 1994;4(5):351-9.
Iso H, Koike KA, Folsom AR, et al. "Lipoprotein(a) and its correlates in Japanese and U.S. population samples." Ann Epidemiol. 1996;6(4):324-30.
Kubota Y, Folsom AR, Ballantyne CM. "Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study." Atherosclerosis. 2018;268:63-67.
Pokharel Y, Sun W, Polfus LM, et al. "Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study." Atherosclerosis. 2015;241(2):641-8.
Kitzmiller JP, Foraker RE, Rose KM. "Lipid-lowering pharmacotherapy and socioeconomic status: Atherosclerosis Risk In Communities (ARIC) surveillance study." BMC Public Health. 2013;13:488.

Pages